Active, not recruiting

Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study (BONE)

Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study: an Ambispective, Multicentre, Open Cohort Study

Sponsor
Peking University Third Hospital (Academic or other)
Enrolment
2,000 planned
Conditions
Osteoporosis,Neurological Disorders
Interventions
Exercise,Nutrition,Bisphosphonates,Statins,Calcitonin,Vitamin D,et al.
Ages
adults, older adults
Registry
NCT03401619

From the registry

Epigenetic modification refers to the change of heritable gene expression occurring in the case of unchanged DNA sequence, including DNA methylation, epigenetic modification, RNAS, chromatin modification, etc. The study found that osteoporosis (OSTEOPOROSIS,OP) with neurological disorders is very common, the risk of fracture of patients increased. It is considered that epigenetic regulation plays an important role in the occurrence and development of OP with neurological disorders. In particular, the role and molecular mechanism of epigenetic modification in OP with neurological disorders are not clear, and the results of clinical studies with different sample sizes are not consistent. (1) Two-way continuous queues,an ambispective cohort study, namely: forward-looking queue method (2017-2027) and Retrospective queue method (2007-2017) were used to understand the effect of epigenetic modification on bone mineral density, bone metabolic Biochemical Index, imaging index and fracture incidence of patients with neurological diseases in outpatients and wards, and to provide basis for…

Primary outcomes

  • cognitive impairment improvement
Full record on ClinicalTrials.gov